XTSX
NXG
Market cap20mUSD
Oct 21, Last price
0.40CAD
Name
NexgenRx Inc
Chart & performance
P/E
21.83
P/S
1.61
EPS
0.02
Div yield, %
—
Shrs. gr., 5y
1.96%
Rev. gr., 5y
10.89%
Revenues
17m
+5.99%
Net income
1m
+109.69%
CFO
146k
-87.32%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company was founded by Ronald Campbell Loucks in 2003 and is headquartered in Toronto, Canada.
Key people
Thomas F. Corcoran
Chairman of the Board · since 2006
Ronald C. Loucks
President, Chief Executive Officer, Director · since 2003
Kelly Ehler
Interim Chief Financial Officer · since 2016
Patrick G. Crowley
Director · since 2008
Randy McGlynn
Director · since 2018
Director · since 2013
Ralph Soberano
Director · since 2006
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||